Bergman L W, Harris E, Kuehl W M
J Biol Chem. 1981 Jan 25;256(2):701-6.
Analysis of nascent heavy chains isolated from MPC11 (gamma 2b heavy chains) and MOPC 21 (gamma 1 heavy chains) mouse myeloma cells demonstrates an accumulation of nascent heavy chains which are slightly smaller in mass (approximately 35,000 daltons) than nascent heavy chains which have just been glycosylated (approximately 38,000 daltons). The accumulation of 35,000-dalton nascent heavy chain appears to be a consequence of the glycosylation process since tunicamycin, an inhibitor of glycosylation, abolishes the apparent translational block manifested by the accumulation of 35,000-dalton nascent chains. Tunicamycin also causes a 15 to 25% increase n the relative rate of synthesis of heavy chain compared to the corresponding rate of synthesis of the nonglycosylated light chain synthesized by the same cell. These results suggest that the translation block, caused by the glycosylation process, of heavy chain synthesis contributes to the imbalance of heavy chain and light chain biosynthesis observed in malignant and normal lymphoid cells.
对从MPC11(γ2b重链)和MOPC 21(γ1重链)小鼠骨髓瘤细胞中分离出的新生重链进行分析,结果显示,与刚进行糖基化的新生重链(约38,000道尔顿)相比,质量略小(约35,000道尔顿)的新生重链出现了积累。35,000道尔顿新生重链的积累似乎是糖基化过程的结果,因为糖基化抑制剂衣霉素消除了由35,000道尔顿新生链积累所表现出的明显翻译阻滞。与同一细胞合成的非糖基化轻链的相应合成速率相比,衣霉素还使重链的相对合成速率提高了15%至25%。这些结果表明,糖基化过程导致的重链合成翻译阻滞,促成了在恶性和正常淋巴细胞中观察到的重链和轻链生物合成失衡。